UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by TCI Wealth Advisors Inc.

TCI Wealth Advisors Inc. lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,719 shares of the healthcare conglomerate’s stock after selling 37 shares during the quarter. TCI Wealth Advisors Inc.’s holdings in UnitedHealth Group were worth $905,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. W.H. Cornerstone Investments Inc. increased its position in shares of UnitedHealth Group by 1.8% during the fourth quarter. W.H. Cornerstone Investments Inc. now owns 1,604 shares of the healthcare conglomerate’s stock worth $845,000 after acquiring an additional 28 shares during the period. Evergreen Wealth Management LLC raised its position in UnitedHealth Group by 1.8% in the 4th quarter. Evergreen Wealth Management LLC now owns 2,032 shares of the healthcare conglomerate’s stock valued at $1,070,000 after purchasing an additional 35 shares in the last quarter. Clearstead Trust LLC grew its position in shares of UnitedHealth Group by 17.2% during the fourth quarter. Clearstead Trust LLC now owns 12,695 shares of the healthcare conglomerate’s stock worth $6,683,000 after buying an additional 1,861 shares in the last quarter. SYM FINANCIAL Corp raised its holdings in UnitedHealth Group by 30.1% in the fourth quarter. SYM FINANCIAL Corp now owns 579 shares of the healthcare conglomerate’s stock valued at $305,000 after acquiring an additional 134 shares in the last quarter. Finally, NavPoint Financial Inc. purchased a new stake in shares of UnitedHealth Group in the 4th quarter valued at approximately $632,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE UNH traded down $0.52 during midday trading on Friday, reaching $492.45. 2,487,811 shares of the company traded hands, compared to its average volume of 5,130,659. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. The firm has a market cap of $453.09 billion, a PE ratio of 30.10, a PEG ratio of 1.43 and a beta of 0.55. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70. The stock’s 50-day simple moving average is $482.32 and its 200-day simple moving average is $512.42.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. During the same period in the previous year, the business posted $6.26 EPS. The company’s quarterly revenue was up 8.6% compared to the same quarter last year. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were issued a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a yield of 1.53%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is 45.97%.

Analysts Set New Price Targets

Several equities analysts recently commented on the company. Oppenheimer reissued an “outperform” rating and issued a $610.00 target price on shares of UnitedHealth Group in a report on Wednesday, January 17th. StockNews.com cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th. Piper Sandler upped their price objective on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Royal Bank of Canada lowered their target price on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a report on Wednesday, April 17th. Finally, Wells Fargo & Company cut their price target on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating for the company in a report on Monday, April 8th. Four analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus price target of $570.05.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.